1. Medtech Insight
  2. >>Device Area
  3. >>Diabetic Care

Dexcom Puts Stelo On Amazon, Setting Up Consumer Showdown With Abbott

New Channel Will Broaden Stelo’s Reach Across Type 2 Diabetes, Prediabetes And Lifestyle Segments.

 
• By Shubham Singh

In addition to broader distribution, Dexcom is investing heavily in software enhancements for Stelo. The 180-day data lookback feature is just one of several planned upgrades intended to improve personalization and user engagement.

The move to go beyond Dexcom’s own online storefront into a popular e-commerce platform signals more than just expanded distribution.
Key Takeaways
  • Amazon access will reduce adoption friction, especially for first-time CGM users.

Dexcom’s decision to launch its over-the-counter continuous glucose monitoring (CGM) system, Stelo, on Amazon places it squarely in a direct-to-consumer...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diabetic Care

More from Digital Technologies

First AI Breast Cancer Prediction Platform Receives FDA Authorization

 
• By Natasha Barrow

Clairity’s "first-in-class" mammography-based AI screening tool, Clairity Breast, provides "equitable risk assessments," expanding access to lifesaving early detection for breast cancer, said company founder Connie Lehman.

ConcertAI Launches Generative AI-Powered Precision Suite

 
• By Natasha Barrow

Valued at over $1.9bn, ConcertAI is building on its pre-existing multi-agentic AI SaaS solution CARAai to bring life science customers the new Precision suite of applications: Precision Explorer, Precision Trials, Precision GTM and Precision360.

Handheld Diagnostics: A Resurging Category That is Here to Stay

 
• By Barnaby Pickering

Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.